N-6-cyclopentyl-3'-substituted-xylofuranosyladenosines: A new class of non-xanthine adenosine A(1) receptor antagonists

被引:18
|
作者
VanCalenbergh, S
vonFrijtag, JK
Kunzel, D
Blaton, NM
Peeters, OM
Rozenski, J
VanAerschot, A
DeBruyn, A
DeKeukeleire, D
Ijzerman, AP
Herdewijn, P
机构
[1] STATE UNIV GHENT,MED CHEM LAB,FFW,B-9000 GHENT,BELGIUM
[2] LEIDEN AMSTERDAM CTR DRUG RES,DIV MED CHEM,NL-2300 RA LEIDEN,NETHERLANDS
[3] KATHOLIEKE UNIV LEUVEN,FAC PHARMACEUT SCI,LAB ANALYT CHEM & MED PHYSICOCHEM,B-3001 LOUVAIN,BELGIUM
[4] KATHOLIEKE UNIV LEUVEN,REGA INST,MED CHEM LAB,B-3001 LOUVAIN,BELGIUM
关键词
D O I
10.1021/jm970176k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study explores the C-3' site of the 3-deoxy-3-xylofuranosyl ring of nucleoside analogues with an adenine or N-6-cyclopentyladenine (CPA) base moiety and evaluates the effect on adenosine receptor affinity. Two series of sugar-modified adenosines, i.e., 3'-amido-3'-deoxyadenosines and 3'-amidated 3'-deoxyxylofuranosyladenines, were synthesized and tested for their affinity at A(1) and A(2a) receptors in rat brain cortex and rat striatum, respectively. The modest affinity found in the ''xylo series'' prompted us to synthesize the corresponding N-6-cyclopentyl derivatives, which proved to be well accommodated by the A(1) receptors with potencies in the lower nanomolar range. This represents a new perspective in the purinergic field. The absence of a GTP-induced shift, i.e., the ratio between the affinities measured in the presence and absence of 1 mM GTP indicates an antagonistic behavior of this new class of CPA analogues.
引用
收藏
页码:3765 / 3772
页数:8
相关论文
共 50 条
  • [31] N6-substituted deoxy adenosine derivatives as adenosine A1 receptor partial agonists
    Lambertucci, Catia
    Antonini, Ippolito
    Buccioni, Michela
    Marucci, Gabriella
    Vittori, Sauro
    Volpini, Rosaria
    Klotz, Karl-Norbert
    Cristalli, Gloria
    PURINERGIC SIGNALLING, 2010, 6 (01) : 92 - 92
  • [32] RELEASE OF ATRIAL-NATRIURETIC-FACTOR INDUCED BY THE A(1)-ADENOSINE RECEPTOR AGONIST 2-CHLORO-N6-CYCLOPENTYL-ADENOSINE IN THE RAT
    MASSI, M
    SAIJA, A
    CRISTALLI, G
    POLIDORI, C
    PERFUMI, M
    COSTA, G
    PHARMACOLOGICAL RESEARCH, 1992, 25 (04) : 393 - 402
  • [33] Process improvements in the production of a novel non-xanthine adenosine A1 receptor antagonist.: A "one-pot" Horner-Emmons isomerization reaction
    Zanka, A
    Itoh, N
    Kuroda, S
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (06) : 394 - 399
  • [34] Novel substituted piperazines: New chemical class of selective 5-HT6 receptor antagonists
    Shirsath, Vikas S.
    Deshpande, Amol D.
    Dwarampudi, Adi R.
    Bhatta, Venugopala Rao
    Bhosale, Sandeep B.
    Kota, Srinivasulu
    Kandikere, Vishwottam N.
    Kambhampati, Rama S.
    Nirogi, Ramakrishna V. S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [35] Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)pyridazinebutanoic acid (FK838):: A novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity
    Akahane, A
    Katayama, H
    Mitsunaga, T
    Kato, T
    Kinoshita, T
    Kita, Y
    Kusunoki, T
    Terai, T
    Yoshida, K
    Shiokawa, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) : 779 - 783
  • [36] NEW N6-SUBSTITUTED ADENOSINE AND 3′-C- METHYL ADENOSINE DERIVATIVES AS ANTITUMOR AGENTS
    Cappellacci, Loredana
    Petrelli, Riccardo
    Vita, Patrizia
    Franchetti, Palmarisa
    Kusumanchi, Praveen
    Kumar, Mohineesh
    Jayaram, Hiremagalur N.
    Grifantini, Mario
    DRUGS OF THE FUTURE, 2009, 34 : 193 - 193
  • [37] Preclinical evaluation of the new A1 adenosine receptor (A1AR) antagonist [18F]8-cyclopentyl-1-propyl-3-(3-fluoropropyl)xanthine ([18F]CPFPX)
    Holschbach, M
    Boy, C
    Herzog, H
    Wutz, W
    Schmitz, T
    Mühlensiepen, H
    Shah, J
    Müller-Gärtner, HW
    Olsson, RA
    Coenen, HH
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 22P - 22P
  • [38] 1,3,8-SUBSTITUTED AND 1,3,7-SUBSTITUTED XANTHINES - RELATIVE POTENCY AS ADENOSINE RECEPTOR ANTAGONISTS AT THE FROG NEUROMUSCULAR-JUNCTION
    SEBASTIAO, AM
    RIBEIRO, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (01) : 211 - 219
  • [39] New N6- or N(9)-hydroxyalkyl substituted 8-azaadenines or adenines as effective A1 adenosine receptor ligands
    Biagi, G
    Giorgi, I
    Leonardi, M
    Livi, O
    Pacchini, F
    Scartoni, V
    Costa, B
    Lucacchini, A
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (09) : 801 - 810
  • [40] 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists
    Chang, LCW
    Spanjersberg, RF
    Künzel, JKV
    Mulder-Krieger, T
    van den Hout, G
    Beukers, MW
    Brussee, J
    IJzerman, AP
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (26) : 6529 - 6540